Interim Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
|
Revenues and grant income: | ||||
Net patient revenues | $ 269,605,000 | $ 260,077,000 | $ 527,612,000 | $ 516,414,000 |
Other revenues | 12,977,000 | 10,962,000 | 24,533,000 | 22,988,000 |
Government stimulus income | 0 | 320,000 | 0 | 10,940,000 |
Net operating revenues and grant income | 282,582,000 | 271,359,000 | 552,145,000 | 550,342,000 |
Cost and expenses: | ||||
Salaries, wages, and benefits | 175,294,000 | 174,936,000 | 343,118,000 | 345,630,000 |
Other operating | 73,234,000 | 71,311,000 | 144,723,000 | 145,396,000 |
Facility rent | 9,901,000 | 10,411,000 | 19,993,000 | 20,476,000 |
Depreciation and amortization | 10,083,000 | 10,001,000 | 20,131,000 | 19,758,000 |
Interest | 93,000 | 149,000 | 191,000 | 314,000 |
Total costs and expenses | 268,605,000 | 266,808,000 | 528,156,000 | 531,574,000 |
Income from operations | 13,977,000 | 4,551,000 | 23,989,000 | 18,768,000 |
Other income: | ||||
Non–operating income | 3,696,000 | 2,521,000 | 8,019,000 | 5,720,000 |
Unrealized gains/(losses) on marketable equity securities | 4,650,000 | (3,549,000) | 6,036,000 | (423,000) |
Income before income taxes | 22,323,000 | 3,523,000 | 38,044,000 | 24,065,000 |
Income tax provision | (6,406,000) | (1,362,000) | (10,842,000) | (6,555,000) |
Net income | 15,917,000 | 2,161,000 | 27,202,000 | 17,510,000 |
Net loss attributable to noncontrolling interest | 364,000 | 1,042,000 | 802,000 | 1,011,000 |
Net income attributable to National HealthCare Corporation | $ 16,281,000 | $ 3,203,000 | $ 28,004,000 | $ 18,521,000 |
Earnings per share attributable to National HealthCare Corporation stockholders: | ||||
Basic (in dollars per share) | $ 1.06 | $ 0.21 | $ 1.83 | $ 1.20 |
Diluted (in dollars per share) | $ 1.06 | $ 0.21 | $ 1.83 | $ 1.20 |
Basic (in shares) | 15,297,435 | 15,452,402 | 15,317,319 | 15,434,718 |
Diluted (in shares) | 15,322,344 | 15,487,123 | 15,339,240 | 15,475,553 |
Dividends declared per common share (in dollars per share) | $ 0.59 | $ 0.57 | $ 1.16 | $ 1.12 |
X | ||||||||||
- Definition Represents stimulus income from government assistance under the CARES Act. No definition available.
|
X | ||||||||||
- Definition The revenues not separately disclosed. No definition available.
|
X | ||||||||||
- Definition Aggregate dividends declared during the period for each share of common stock outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of operating lease expense. Excludes sublease income. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|